Akari Therapeutics Plc
AKTX · XNASCIK 1541157fmd_13BGEACR9AMDP6EM9R7X82Z5A5Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2006 to Sep 30, 2026, 50 periods
News summary
An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.
AI-written
0 filings
From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).
Loading